Overview

Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
0
Participant gender:
All
Summary
This study is comparing 2 medications for glaucoma and how effective they are at controlling glaucoma over the course of an entire day.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Dorzolamide
Maleic acid
Timolol
Criteria
Inclusion Criteria:

- Patients with glaucoma or ocular hypertension

Exclusion Criteria:

- Other eye conditions

- Poor vision

- Recent eye surgery

- Use of contact lenses

- Nursing or pregnant women

- Use of some other selected medications

- Drug or alcohol abuse

- Asthma

- Slow heart beat

- Allergy or previous reaction to study drugs